@ARTICLE{
author={Pemmaraju Naveen,...,Bogdanovic Andrija D,...,(broj koautora 29)},
year={2026},
title={TRANSFORM-1 phase 3 study: efficacy and safety of navitoclax plus ruxolitinib in patients with untreated myelofibrosis},
journal={BLOOD},
volume={148},
number={16},
pages={2029-2042},
document_type={Article},
} 

@ARTICLE{
author={Pemmaraju Naveen,...,Bogdanovic Andrija D,...,(broj koautora 24)},
year={2023},
title={Transform-1: A Randomized, Double-Blind, Placebo-Controlled, Multicenter, International Phase 3 Study of Navitoclax in Combination with Ruxolitinib Versus Ruxolitinib Plus Placebo in Patients with Untreated Myelofibrosis},
journal={BLOOD},
volume={142},
number={},
pages={-},
document_type={Meeting Abstract},
} 

